evertex fabrinology limited

TWSE:1470 Stock Report

Market Cap: NT$2.1b

evertex fabrinology Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Anthony Yeh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure18.2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.2yrs

Recent management updates

Recent updates

Analysis Article • Nov 19

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Despite posting some strong earnings, the market for evertex fabrinology limited's ( TWSE:1470 ) stock hasn't moved...
Analysis Article • Sep 16

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology limited's ( TWSE:1470 ) price-to-earnings (or "P/E") ratio of 32.9x might make it look like a...
Analysis Article • Mar 20

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

evertex fabrinology limited's ( TWSE:1470 ) stock didn't jump after it announced some healthy earnings. We think that...
Analysis Article • Apr 25

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Is evertex fabrinology limited ( TPE:1470 ) a good dividend stock? How can we tell? Dividend paying companies with...
Analysis Article • Mar 26

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Analysis Article • Mar 05

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

evertex fabrinology's (TPE:1470) stock is up by 3.1% over the past month. However, its weak financial performance...
Analysis Article • Feb 12

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Analysis Article • Jan 25

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Dividend paying stocks like evertex fabrinology limited ( TPE:1470 ) tend to be popular with investors, and for good...
Analysis Article • Jan 07

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While...
Analysis Article • Dec 20

Is evertex fabrinology (TPE:1470) Headed For Trouble?

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Analysis Article • Dec 02

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

evertex fabrinology's (TPE:1470) stock is up by 2.0% over the past week. However, its weak financial performance...

CEO

Anthony Yeh

18.2yrs
Tenure

Mr. Poliang Yeh, also known as Anthony, is President of evertex fabrinology limited and serves as its Director from June 27, 2023.

Board Members

NamePositionTenureCompensationOwnership
Poliang Yeh
President & Director18.2yrsno datano data
Sin-Yi Huang
Independent Director3.2yrsno datano data
Rung-Shin Shu
Director6.2yrsno data2.89%
NT$ 59.6m
Koi-Hui Yeh
Director21.2yrsno data0.30%
NT$ 6.2m
Yao-Chou Yang
Director21.2yrsno data3.71%
NT$ 76.4m
Xianzhong Lian
Directorless than a yearno data0.75%
NT$ 15.4m
Yu-Lun Yeh
Directorless than a yearno datano data
Cong-Wen Shi
Independent Director3.2yrsno datano data
Wei-Min Yeh
Directorless than a yearno datano data
Yuan-Liang Tai
Independent Directorless than a yearno datano data
Jun-Yi Chen
Independent Directorless than a yearno datano data
3.2yrs
Average Tenure

Experienced Board: 1470's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/14 11:45
End of Day Share Price 2026/08/14 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

evertex fabrinology limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.